Integrating New Data From CROI 2020

Join 2 leading experts for an interactive Webinar focused on the most clinically relevant data presented at CROI 2020, as well as other key studies that may be significant to the advancement of HIV patient care. Case vignettes will be used to explore integration of findings into everyday patient management.

Agenda

The timing and agenda for each webinar is as follows:

  • Introduction and Program Overview (5 mins)
  • Key Findings from CROI 2020 (60 mins)
    • Current and Late-Phase Investigational ART
    • Weight Gain and Metabolic Considerations With ART
    • HIV Prevention
    • HIV and Pregnancy
    • Rapid Start
  • Question and Answer Session (25 mins)

Events

Date / Time
Event Details

Faculty

Program Director
Joseph J. Eron, MD

Professor of Medicine and Epidemiology
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Program Director
Princy N. Kumar, MD

Professor of Medicine and Microbiology
Chief,
Division of Infectious Diseases and Travel Medicine
Senior Associate Dean of Students
Georgetown University School of Medicine
Washington, DC

Faculty
Roger Bedimo, MD

Professor of Medicine
Division of Infectious Diseases
University of Texas Southwestern Medical Center
Section Chief
Division of Infectious Diseases
Department of Internal Medicine
VA North Texas Health Care System
Dallas, Texas

Faculty
Eric S. Daar, MD

Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Faculty
David Hardy, MD

Scientific and Medical Consultant
Adjunct Professor of Medicine

Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland

Faculty
Lisa Hightow-Weidman, MD

Professor
Division of Infectious Diseases
Department of Medicine
University of North Carolina, Chapel Hill
Chapel Hill, North Carolina

Faculty
Daniel R. Kuritzkes, MD

Chief, Division of Infectious Diseases
Brigham and Women's Hospital
Harriet Ryan Albee Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Faculty
Mary W. Montgomery, MD

Instructor of Medicine
Harvard Medical School
Associate Professor
Division of Infectious Disease
Department of Medicine
Brigham and Women's Hospital
Boston, Massachusetts

Faculty
Daniel A. Solomon, MD

Instructor of Medicine
Division of Infectious Diseases
Harvard Medical School
Associate Physician
Division of Infectious Diseases
Brigham and Women's Hospital
Boston, Massachusetts

Faculty
Heidi Swygard, MD

Clinical Associate Professor of Medicine
Division of Infectious Diseases
Department of Medicine
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Faculty
Babafemi Taiwo, MBBS

Gene Stollerman Professor of Medicine
Chief,
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Faculty
Marc A. Tribble, MD

Clinical Assistant Professor
Division of Infectious Diseases
Baylor University Medical Center at Dallas
Dallas, Texas

Faculty
Timothy J. Wilkin, MD

Associate Professor of Medicine
Co-Director, Cornell Clinical Trials Unit
Weill Cornell Medical College
New York, New York

Faculty
David A. Wohl, MD

Professor of Medicine
School of Medicine
Site Leader,  AIDS Clinical Trials Unit-Chapel Hill
University of North Carolina at Chapel Hill
Director, North Carolina AIDS Training and Education Center
Chapel Hill, North Carolina
Co-Director, HIV Services
North Carolina Department of Correction
Raleigh, North Carolina

Goal Statement
The goal of this activity is to improve learners’ competence in providing optimal care for HIV-infected patients through the appropriate use of contemporary ARV regimens.

Target Audience
This program is intended for physicians, registered nurses, physician assistants, pharmacists, and other healthcare professionals who provide care for patients with HIV infection.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Appropriately counsel patients regarding data from clinical trials evaluating the use of antiretroviral agents to prevent HIV infection
  • Incorporate the results of recent clinical studies when utilizing antiretroviral agents for individualized management of HIV infection
  • Provide insightful counsel to patients and colleagues regarding studies of investigational antiretroviral agents and strategies in advanced stages of development

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.5 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number - JA4008176-0000-20-041-L02-P

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.